MFDS
- Status: likely_approved
🇰🇷 Litfulo in South Korea
Litfulo (ritlecitinib) regulatory status in South Korea.
Marketing authorisation
Litfulo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in South Korea
Frequently asked questions
Is Litfulo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Litfulo in South Korea?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.